首页> 外文会议>Annual International Vicenza Course on Hemodialysis >Treatment Disparities in Acute Coronary Sy niromes, Heart Failure, and Kidney Disease
【24h】

Treatment Disparities in Acute Coronary Sy niromes, Heart Failure, and Kidney Disease

机译:急性冠状动脉患者,心力衰竭和肾病的治疗差异

获取原文

摘要

It has been consistently observed that patients with renal dysfunction have more premature, severe, complicated, and fatal cardiovascular disease than age- and sex-matched individuals with normal renal function. There have been 4 major explanations for this finding: (1) positive confounding by third variables associated with chronic kidney disease (CKD), including diabetes mellitus and hypertension; (2) therapeutic nihilism or lesser use of beneficial therapies in CKD; (3) greater toxicities of therapies, such as bleeding from anticoagulants or contrast-induced kidney injury; (4) biological factors which result directly from CKD that work to promote and accelerate cardiovascular disease. In this paper, we focus on the issue of treatment disparities or therapeutic nihilism and its contribution to poor outcomes in the setting of acute coronary syndromes and acutely decompensated heart failure. This issue is important because if we can overcome barriers to the utilization of beneficial treatments, then clinical outcomes should improve over time.
机译:它一直观察到肾功能障碍的患者具有比具有正常肾功能正常的年龄和性匹配的个体更早,严重,复杂,致命的心血管疾病更早,严重,复杂和致命的心血管疾病。此发现有4个主要解释:(1)与慢性肾病(CKD)相关的第三种变量的积极混杂,包括糖尿病和高血压; (2)治疗性虚无主义或在CKD中使用有益疗法; (3)疗法的更大毒性,例如抗凝血剂或对比诱导的肾损伤的出血; (4)直接从CKD产生的生物因素,这些因素促进和加速心血管疾病。在本文中,我们专注于治疗差异或治疗性虚无主义的问题,以及在急性冠状动脉综合征和急性失代偿的心力衰竭的情况下对差的结果造成贡献。这个问题很重要,因为如果我们能够克服利用有益治疗的障碍,那么临床结果应随着时间的推移而改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号